» Articles » PMID: 20110593

A Versatile High Throughput Screening System for the Simultaneous Identification of Anti-inflammatory and Neuroprotective Compounds

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2010 Jan 30
PMID 20110593
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In many chronic neurodegenerative diseases including Frontotemporal Dementia and Alzheimer's disease (AD), microglial activation is suggested to be involved in pathogenesis or disease progression. Activated microglia secrete a variety of cytokines, including interleukin-1beta, interleukin-6, and tumor necrosis factor as well as reactive oxygen and nitrogen species (ROS/RNS). ROS and RNS contribute to alterations in neuronal glucose uptake, inhibition of mitochondrial enzymes, a decrease in mitochondrial membrane potential, impaired axonal transport, and synaptic signaling. In addition, ROS act as signaling molecules in pro-inflammatory redox-active signal transduction pathways. To establish a high throughput screening system for anti-inflammatory and neuroprotective compounds, we have constructed an "Enhanced Green Fluorescent protein" (EGFP) expressing neuronal cell line and set up a murine microglia/neuron co-culture system with these EGFP expressing neuronal cells. We show that microglia activation leads to neuronal cell death, which can be conveniently measured by loss of neuronal EGFP fluorescence. Moreover, we used this system to test selected polyphenolic compounds for their ability to downregulate inflammatory markers and to protect neurons against microglial insult. We suggest that this system might allow accelerated drug discovery for the treatment of inflammation-mediated neurodegenerative diseases.

Citing Articles

A bottom-up approach identifies the antipsychotic and antineoplastic trifluoperazine and the ribose derivative deoxytubercidin as novel microglial phagocytosis inhibitors.

Rodriguez-Iglesias N, Paris I, Valero J, Canas-Zabala L, Carretero A, Hatje K Glia. 2024; 73(2):330-351.

PMID: 39495090 PMC: 11662983. DOI: 10.1002/glia.24637.


Integrating Network Pharmacology and Component Analysis to Study the Potential Mechanisms of Qi-Fu-Yin Decoction in Treating Alzheimer's Disease.

Lei X, Xu H, Wang Y, Gao H, Zhao D, Zhang J Drug Des Devel Ther. 2023; 17:2841-2858.

PMID: 37727255 PMC: 10506672. DOI: 10.2147/DDDT.S402624.


From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery-An Australian Example.

Kumar P, Mathew S, Gamage R, Bodkin F, Doyle K, Rossetti I Int J Mol Sci. 2023; 24(13).

PMID: 37446262 PMC: 10342267. DOI: 10.3390/ijms241311086.


Development of Novel Herbal Compound Formulations Targeting Neuroinflammation: Network Pharmacology, Molecular Docking, and Experimental Verification.

Liu Y, Chang D, Zhou X Evid Based Complement Alternat Med. 2023; 2023:2558415.

PMID: 37266321 PMC: 10232107. DOI: 10.1155/2023/2558415.


The link between neuroinflammation and the neurovascular unit in synucleinopathies.

Wang Q, Zheng J, Pettersson S, Reynolds R, Tan E Sci Adv. 2023; 9(7):eabq1141.

PMID: 36791205 PMC: 9931221. DOI: 10.1126/sciadv.abq1141.